Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Carbetocin is noninferior to oxytocin to prevent postpartum hemorrhage with better heat stability

July 5, 2018

Cereno reports results from first clinical study of CS-1

July 3, 2018

EMA committee recommends marketing authorization for Veyvondi

July 2, 2018

Refixia obtain Japanese approval for the treatment of hemophilia B

July 2, 2018

EMA committee recommends approval of Cablivi for aTTP

June 29, 2018

Phase III MEDALIST study of luspatercept meets primary and key secondary endpoints

June 29, 2018

Alexion seeks E.U. approval for ALXN-1210 for PNH

June 28, 2018

Apellis initiates phase III trial of APL-2 in PNH

June 27, 2018

Alexion submits U.S. BLA for ALXN-1210 to treat PNH

June 19, 2018

Catalyst offers update from Cohort 6 in phase I/II trial of CB-2679d for hemophilia B

June 19, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...